ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      6,040.78
      0.47%
      US Tech 100
      20,758.80
      0.93%
      Dow Jones
      44,886.86
      0.39%
      Brent Oil
      76.295
      0.03%
      Bitcoin
      102,811.12
      0.73%
      Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ

      6. GRAIL Inc (GRAL) Quote

      GRAIL Inc

      GRAIL Inc (GRAL)

      Grifal SpA
      26.685
      0.695
      ( 2.67% )
      Updated: 10:31:14
      Delayed by 15 minutes

      Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

      Premium

      Key stats and details

      Current Price
      26.685
      Bid
      26.63
      Ask
      26.75
      Volume
      134,408
      25.79 Day's Range 26.9961
      12.33 52 Week Range 29.79
      Market Cap
      896.637M
      Previous Close
      25.99
      Open
      26.55
      Last Trade
      1
      @
      26.685
      Last Trade Time
      10:31:15
      Financial Volume
      $ 3,570,161
      VWAP
      26.5621
      Average Volume (3m)
      953,830
      Shares Outstanding
      33,600,772
      Dividend Yield
      -
      PE Ratio
      -0.60
      Earnings Per Share (EPS)
      -43.62
      Revenue
      93.11M
      Net Profit
      -1.47B

      About GRAIL Inc

      GRAIL is a healthcare company innovating to solve medicine's most important challenges. The Company's team of leading scientists, engineers and clinicians are on an urgent mission to detect cancer early, when it may be more treatable and potentially curable. GRAIL is a healthcare company innovating to solve medicine's most important challenges. The Company's team of leading scientists, engineers and clinicians are on an urgent mission to detect cancer early, when it may be more treatable and potentially curable.

      Sector
      Medical Laboratories
      Industry
      Medical Laboratories
      Website
      grail.com
      Headquarters
      Wilmington, Delaware, USA
      Founded
      -
      GRAIL Inc is listed in the Medical Laboratories sector of the NASDAQ with ticker GRAL. The last closing price for GRAIL was $25.99. Over the last year, GRAIL shares have traded in a share price range of $ 12.33 to $ 29.79.

      GRAIL currently has 33,600,772 shares outstanding. The market capitalization of GRAIL is $873.28 million. GRAIL has a price to earnings ratio (PE ratio) of -0.60.

      Ask ADVFN Intelligence (AI)

      GRAL Latest News

      More News

      FeaturedLaFleur Minerals Provides Updates on Exploration at Swanson Gold Deposit and Plans to Restart of Beacon Gold Mill

      January 27 2025

      Form 8-K - Current report

      January 15 2025
      Edgar (US Regulatory)

      Patient Reported Outcomes for GRAIL's Galleri® Multi-Cancer Early Detection Blood Test Published in Lancet Oncology

      Patient Reported Outcomes for GRAIL's Galleri® Multi-Cancer Early Detection Blood Test Published in Lancet Oncology PR Newswire MENLO PARK, Calif., Jan. 13, 2025 Analysis of Patient Reported...

      January 13 2025
      PR Newswire (US)

      GRAIL to Present at the 43rd Annual J.P. Morgan Healthcare Conference

      GRAIL to Present at the 43rd Annual J.P. Morgan Healthcare Conference PR Newswire MENLO PARK, Calif., Dec. 18, 2024 MENLO PARK, Calif., Dec. 18, 2024 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL), a...

      December 18 2024
      PR Newswire (US)

      GRAIL Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

      GRAIL Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) PR Newswire MENLO PARK, Calif., Dec. 3, 2024 MENLO PARK, Calif., Dec. 3, 2024 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL), a...

      December 03 2024
      PR Newswire (US)

      Form 4 - Statement of changes in beneficial ownership of securities

      November 19 2024
      Edgar (US Regulatory)

      GRAIL to Participate in Upcoming Investor Conferences

      GRAIL to Participate in Upcoming Investor Conferences PR Newswire MENLO PARK, Calif., Nov. 19, 2024 MENLO PARK, Calif., Nov. 19, 2024 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL), a healthcare...

      November 19 2024
      PR Newswire (US)

      GRAIL Announces First Patient Tested With Blood-Based Assay in Global Phase 3 Adjuvant Lung Cancer Study

      GRAIL Announces First Patient Tested With Blood-Based Assay in Global Phase 3 Adjuvant Lung Cancer Study PR Newswire MENLO PARK, Calif., Nov. 18, 2024 MENLO PARK, Calif., Nov. 18, 2024 ...

      November 18 2024
      PR Newswire (US)

      Form 144 - Report of proposed sale of securities

      November 15 2024
      Edgar (US Regulatory)

      Form 10-Q - Quarterly report [Sections 13 or 15(d)]

      November 13 2024
      Edgar (US Regulatory)
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      18.87549.83155530617.8129.7917.6801186898224.77329783CS
      47.85541.715347849218.8329.7916.56100079121.16553705CS
      1212.55588.853503184714.1329.7913.5295383019.19558891CS
      2610.14561.336154776316.5429.7912.3384441116.79055835CS
      528.05543.236714975818.6329.7912.33108974916.59651064CS
      1568.05543.236714975818.6329.7912.33108974916.59651064CS
      2608.05543.236714975818.6329.7912.33108974916.59651064CS

      GRAL - Frequently Asked Questions (FAQ)

      What is the current GRAIL share price?
      The current share price of GRAIL is $ 26.685
      How many GRAIL shares are in issue?
      GRAIL has 33,600,772 shares in issue
      What is the market cap of GRAIL?
      The market capitalisation of GRAIL is USD 873.28M
      What is the 1 year trading range for GRAIL share price?
      GRAIL has traded in the range of $ 12.33 to $ 29.79 during the past year
      What is the PE ratio of GRAIL?
      The price to earnings ratio of GRAIL is -0.6
      What is the cash to sales ratio of GRAIL?
      The cash to sales ratio of GRAIL is 9.51
      What is the reporting currency for GRAIL?
      GRAIL reports financial results in USD
      What is the latest annual turnover for GRAIL?
      The latest annual turnover of GRAIL is USD 93.11M
      What is the latest annual profit for GRAIL?
      The latest annual profit of GRAIL is USD -1.47B
      What is the registered address of GRAIL?
      The registered address for GRAIL is CORPORATION TRUST CENTER, 1209 ORANGE ST, NEW CASTLE, WILMINGTON, DELAWARE, 19801
      What is the GRAIL website address?
      The website address for GRAIL is grail.com
      Which industry sector does GRAIL operate in?
      GRAIL operates in the MEDICAL LABORATORIES sector

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      SLXNSilexion Therapeutics Corporation
      $ 1.22
      (110.34%)
      		139.26M
      YIBOPlanet Image International Ltd
      $ 4.9808
      (61.71%)
      		42.66M
      TRIBTrinity Biotech PLC
      $ 1.20
      (57.89%)
      		90.99M
      HEPAHepion Pharmaceuticals Inc
      $ 0.2478
      (50.18%)
      		169.73M
      RNAZTransCode Therapeutics Inc
      $ 10.054
      (47.20%)
      		5.49M
      LPTXLeap Therapeutics Inc
      $ 0.655
      (-70.89%)
      		5.62M
      STSSSharps Technology Inc
      $ 0.4585
      (-68.60%)
      		8.73M
      SABSSAB Biotherapeutics Inc
      $ 2.15
      (-50.69%)
      		676.27k
      MGOLMGO Global Inc
      $ 0.172
      (-39.22%)
      		10.59M
      JGAurora Mobile Ltd
      $ 10.21
      (-29.73%)
      		1.26M
      HEPAHepion Pharmaceuticals Inc
      $ 0.2481
      (50.36%)
      		169.73M
      NVDANVIDIA Corporation
      $ 121.00
      (2.18%)
      		159.51M
      SLXNSilexion Therapeutics Corporation
      $ 1.22
      (110.34%)
      		139.26M
      TRIBTrinity Biotech PLC
      $ 1.20
      (57.89%)
      		91M
      BACKIMAC Holdings Inc
      $ 1.095
      (32.09%)
      		50.03M

      Discussion

      View Full Feed
      Number sleven Number sleven 3 minutes ago
      JRoon,
      https://www.pharmaceutical-technology.com/contractors/contract-manufacturers/patheon-inc/pressreleases/presspatheon-acquisition-banner-pharmacaps/
      Banner pharmacaps was encapsulating vascepa at one point. (Netherlands).
      Sleven,
      AMRN
      GREEN MAKER GREEN MAKER 3 minutes ago
      Is anyone able to place a buy order?
      VVWT
      MartinLutherKing MartinLutherKing 3 minutes ago
      Hail the holy grail in cancer research 🚀🚀🚀
      RNAZ
      Chartmaster Chartmaster 3 minutes ago
      YW, just a matter of time and this will run!
      NWPN
      misterfishman misterfishman 3 minutes ago
      hmmm i knew a girl like that in my youth but i didnt mind because she had a snapping p.---y l lol
      IGPK
      Golden Cross Golden Cross 3 minutes ago
      $GRLF Triple Zero Stocks: High-Risk OTC Plays with Big Gain Potential
      https://allcapresearch.com/f/triple-zero-stocks-high-risk-otc-plays-with-big-gain-potential
      GRLF
      luckydude777 luckydude777 3 minutes ago
      Short squeeze may be unfolding on RNAZ
      RNAZ
      Golden Cross Golden Cross 4 minutes ago
      $GRLF Triple Zero Stocks: High-Risk OTC Plays with Big Gain Potential
      https://allcapresearch.com/f/triple-zero-stocks-high-risk-otc-plays-with-big-gain-potential
      GRLF
      Stumblebum Stumblebum 4 minutes ago
      Wow where is the bottom
      UNCY
      linkvest linkvest 4 minutes ago
      Tomorrow is Chinese New Year...... Year of the Snake.... In 2025, the Chinese zodiac signs expected to experience excellent fortune include Ox, Dragon, Snake, Rat, and Rooster.
      IGPK
      koolmc koolmc 4 minutes ago
      0.0007 hitting
      EEGI
      rstar rstar 5 minutes ago
      .39s getting tapped. we all know how thin this is! bring on the volume!!!
      TGLO
      FDApproved FDApproved 5 minutes ago
      New Company Presentation !!!

      https://pluri-biotech.com/presentation/
      PLUR
      jem1 jem1 5 minutes ago
      Again..Thanks!!Chartmaster..for..the..News..Update!
      NWPN
      MartinLutherKing MartinLutherKing 5 minutes ago
      The world is watching https://jonrappoport.substack.com/p/rna-cancer-vaccines-created-by-ai-for-500-billion-dollars?utm_campaign=post&utm_medium=web
      RNAZ
      falkus951 falkus951 5 minutes ago
      it has potential! BOOM
      AEXAY
      againstallodds againstallodds 5 minutes ago
      And still no gold, not even ore milling!!!

      There is only Pom-Pom pumping.

      Still no beef

      No new ore shipments from the fran

      Nothing reported at Mt Vernon

      Converted shares about to hit the market

      JarHead stretchi
      NBRI
      k9uwa k9uwa 5 minutes ago
      One of my Stink Bids filled $9.60 Eventually sell the trade shares when they are up. Or probably I will just keep them for the later payoff.
      All is House Money due to 2021 sold all. In a way the MAB's are helping us. I heard that in Calif to get on a MAB required two specialists.
      Bett
      AVXL
      Genz2 Genz2 5 minutes ago
      Methinks, where I used to work, we used to have to put in an MML (Monthly Management Letter) what we have done for the company…. I think you and I could put in a lot of our posts into those letters for Wave!!! They say ask and you shall receive, well I feel like when Wave makes it BIG we should be
      double_m double_m 5 minutes ago
      Seems like multiple articles on eVTOL everyday. A lot of anticipation for manifestation into a massive success or an absolute failure. However it plays out, this is a massive financial opportunity!

      https://www.msn.com/en-us/money/topstocks/joby-aviation-stock-buy-sell-or-hold/ar-AA1x
      JOBY
      Angelmin Angelmin 5 minutes ago
      Booooooom! - life is beautiful 🤩!
      FNMA
      Moonboy1 Moonboy1 5 minutes ago
      Just keeps stair stepping. Almost too good to be true. I'm just wondering what's actually going on here. Who's buying these Shares? Call me a conspiracy theorist but It's a no brainer that billionaires have the inside track with people in the FDA. So maybe some institutions know this is getting appr
      TNXP

      Your Recent History

      NASDAQ
      GRAL
      GRAIL
      NASDAQ
      EYES
      Second Sight Medical Pro...
      Delayed Upgrade Clock

      Go Ad-Free

      Subscribe to Ad free and enjoy an ad-free experience

      No Ads

      Try Now

      Keep the Ads